Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 17, 2026
TSMC (TSM) Reports +36% Revenue Jump in Q2, Raises 2026 Outlook

TSMC (TSM) Reports +36% Revenue Jump in Q2, Raises 2026 Outlook

Key Takeaways

  • Second quarter revenue reached US$40.20 billion, up 36.0% year-over-year and 12.0% sequentially, at the high end of guidance.
  • Diluted EPS came in at US$4.31, a 77.4% increase year-over-year, exceeding analyst estimates.
  • Gross margin expanded to 67.7%, supported by strong demand for advanced process nodes.
  • Advanced technologies (7-nanometer and below) accounted for 77% of wafer revenue, with 2-nanometer ramping up.
  • The company raised its full-year 2026 revenue growth outlook to slightly above 40%.
  • Shares showed limited movement in regular trading following the release, with modest after-hours adjustment.

Why These Results Matter

TSMC serves as the world’s leading contract chip manufacturer, producing semiconductors for major technology firms including those driving artificial intelligence applications. The second quarter results highlight continued momentum in high-performance computing, which has become the dominant revenue driver. Investors closely monitor these reports for signals on AI-related capital spending and technology adoption trends, given TSMC’s central role in the global semiconductor supply chain. Strong quarterly performance often influences broader market sentiment toward the sector.

Breaking Down the Q2 Figures

For the second quarter ended June 30, 2026, TSMC reported consolidated revenue of NT$1,270.38 billion (US$40.20 billion), representing a 36.0% year-over-year increase and a 12.0% sequential gain. Net income rose 77.4% year-over-year to NT$706.56 billion. Diluted earnings per share reached NT$27.25 (US$4.31 per American depositary receipt). Gross margin stood at 67.7%, operating margin at 60.3%, and net profit margin at 55.6%. Revenue exceeded the company’s guidance range of US$39.0 billion to US$40.2 billion and topped analyst forecasts of approximately US$39.94 billion. Advanced process technologies accounted for 77% of wafer revenue, underscoring demand for cutting-edge nodes. I also checked this using Tickeron’s AI Screener to compare the stock against peers in the sector.

Market Reaction and Sentiment

Following the July 16, 2026, release, TSM shares exhibited modest movement during regular trading hours. The results, which included a raised full-year outlook, reinforced positive sentiment around AI-driven demand. Some investors noted the company’s increased capital expenditure plans, including additional commitments in Arizona, which contributed to a slight after-hours pullback as the market digested implications for near-term margins.

Using AI Tools to Refine the Picture

In my own workflow, I regularly turn to Tickeron’s AI Screener when evaluating earnings releases like this one. The tool lets me filter thousands of stocks and ETFs by technical patterns, fundamentals, volatility, and AI-driven signals, making it easier to spot how TSM stacks up against other names in the semiconductor space. Customizable screens for industry, market cap, price patterns, and performance metrics help surface trade ideas and breakout candidates without spending hours on manual research. I find it especially useful for quickly confirming whether a name showing strong AI exposure is also appearing on other investors’ radars.

Forward Outlook and Factors to Watch

Management provided third-quarter 2026 guidance calling for revenue between US$44.6 billion and US$45.8 billion. Gross margin is expected in the 65% to 67% range, and operating margin between 56% and 58%, assuming an exchange rate of 32 New Taiwan dollars per U.S. dollar.

Investors should watch the continued ramp of 2-nanometer technology and overall utilization rates across advanced nodes. Demand signals from artificial intelligence customers remain a key focus, as high-performance computing platforms now represent a significant portion of revenue. Additional factors include currency fluctuations, given the impact of exchange rates on reported margins, and progress on capacity expansions. The company’s updated full-year growth target offers further context for assessing sustained momentum through the remainder of 2026.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TSM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


TSM in upward trend: price may jump up because it broke its lower Bollinger Band on July 29, 2026

TSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where TSM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TSM's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on TSM as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TSM just turned positive on August 04, 2026. Looking at past instances where TSM's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TSM advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

TSM moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TSM crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TSM entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.180) is normal, around the industry mean (8.255). P/E Ratio (32.385) is within average values for comparable stocks, (166.349). Projected Growth (PEG Ratio) (1.035) is also within normal values, averaging (1.917). Dividend Yield (0.008) settles around the average of (0.015) among similar stocks. P/S Ratio (16.181) is also within normal values, averaging (48.472).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 189.91B. The market cap for tickers in the group ranges from 13.43K to 5.43T. NVDA holds the highest valuation in this group at 5.43T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 5%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 46%. WOLF experienced the highest price growth at 26%, while LASR experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 53
Price Growth Rating: 49
SMR Rating: 76
Profit Risk Rating: 73
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
TSM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of integrated circuits, silicon wafers, diodes and related semiconductor components

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
No. 8, Li-Hsin Road 6
Phone
+886 35636688
Employees
61777
Web
https://www.tsmc.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.